The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Influenza Drugs and Vaccines Market Research Report 2024
Synopsis
The Influenza Drugs and Vaccines market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Influenza Drugs and Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Influenza Drugs and Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CSL
Bristol Myers Squibb
AstraZeneca
Eli Lilly
Roche
GlaxoSmithKline
Novartis
Pfizer
Sanofi
Bayer
Celgene
Seqirus
Protein Sciences Corporation
Serum Institute of India
Emergent Biosolutions
BioCryst Pharmaceuticals
Alvogen
Viatris
Hulan Bio
Changchun Institute of Biological
Jiangsu GDK
Sinovac
Beike Bio
Segment by Type
Influenza Drugs
Influenza Vaccines
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Influenza Drugs and Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Influenza Drugs and Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The Influenza Drugs and Vaccines market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Influenza Drugs and Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Influenza Drugs and Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CSL
Bristol Myers Squibb
AstraZeneca
Eli Lilly
Roche
GlaxoSmithKline
Novartis
Pfizer
Sanofi
Bayer
Celgene
Seqirus
Protein Sciences Corporation
Serum Institute of India
Emergent Biosolutions
BioCryst Pharmaceuticals
Alvogen
Viatris
Hulan Bio
Changchun Institute of Biological
Jiangsu GDK
Sinovac
Beike Bio
Segment by Type
Influenza Drugs
Influenza Vaccines
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Influenza Drugs and Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Influenza Drugs and Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Influenza Drugs and Vaccines Market Overview
1.1 Product Overview and Scope of Influenza Drugs and Vaccines
1.2 Influenza Drugs and Vaccines Segment by Type
1.2.1 Global Influenza Drugs and Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Influenza Drugs
1.2.3 Influenza Vaccines
1.3 Influenza Drugs and Vaccines Segment by Application
1.3.1 Global Influenza Drugs and Vaccines Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Influenza Drugs and Vaccines Market Size Estimates and Forecasts
1.4.1 Global Influenza Drugs and Vaccines Revenue 2019-2030
1.4.2 Global Influenza Drugs and Vaccines Sales 2019-2030
1.4.3 Global Influenza Drugs and Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Influenza Drugs and Vaccines Market Competition by Manufacturers
2.1 Global Influenza Drugs and Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Influenza Drugs and Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Influenza Drugs and Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Influenza Drugs and Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Influenza Drugs and Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Influenza Drugs and Vaccines, Product Type & Application
2.7 Influenza Drugs and Vaccines Market Competitive Situation and Trends
2.7.1 Influenza Drugs and Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Influenza Drugs and Vaccines Players Market Share by Revenue
2.7.3 Global Influenza Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Influenza Drugs and Vaccines Retrospective Market Scenario by Region
3.1 Global Influenza Drugs and Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Influenza Drugs and Vaccines Global Influenza Drugs and Vaccines Sales by Region: 2019-2030
3.2.1 Global Influenza Drugs and Vaccines Sales by Region: 2019-2024
3.2.2 Global Influenza Drugs and Vaccines Sales by Region: 2025-2030
3.3 Global Influenza Drugs and Vaccines Global Influenza Drugs and Vaccines Revenue by Region: 2019-2030
3.3.1 Global Influenza Drugs and Vaccines Revenue by Region: 2019-2024
3.3.2 Global Influenza Drugs and Vaccines Revenue by Region: 2025-2030
3.4 North America Influenza Drugs and Vaccines Market Facts & Figures by Country
3.4.1 North America Influenza Drugs and Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Influenza Drugs and Vaccines Sales by Country (2019-2030)
3.4.3 North America Influenza Drugs and Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Influenza Drugs and Vaccines Market Facts & Figures by Country
3.5.1 Europe Influenza Drugs and Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Influenza Drugs and Vaccines Sales by Country (2019-2030)
3.5.3 Europe Influenza Drugs and Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Influenza Drugs and Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Influenza Drugs and Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Influenza Drugs and Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Influenza Drugs and Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Influenza Drugs and Vaccines Market Facts & Figures by Country
3.7.1 Latin America Influenza Drugs and Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Influenza Drugs and Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Influenza Drugs and Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Influenza Drugs and Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Influenza Drugs and Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Influenza Drugs and Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Influenza Drugs and Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Influenza Drugs and Vaccines Sales by Type (2019-2030)
4.1.1 Global Influenza Drugs and Vaccines Sales by Type (2019-2024)
4.1.2 Global Influenza Drugs and Vaccines Sales by Type (2025-2030)
4.1.3 Global Influenza Drugs and Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Influenza Drugs and Vaccines Revenue by Type (2019-2030)
4.2.1 Global Influenza Drugs and Vaccines Revenue by Type (2019-2024)
4.2.2 Global Influenza Drugs and Vaccines Revenue by Type (2025-2030)
4.2.3 Global Influenza Drugs and Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Influenza Drugs and Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Influenza Drugs and Vaccines Sales by Application (2019-2030)
5.1.1 Global Influenza Drugs and Vaccines Sales by Application (2019-2024)
5.1.2 Global Influenza Drugs and Vaccines Sales by Application (2025-2030)
5.1.3 Global Influenza Drugs and Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Influenza Drugs and Vaccines Revenue by Application (2019-2030)
5.2.1 Global Influenza Drugs and Vaccines Revenue by Application (2019-2024)
5.2.2 Global Influenza Drugs and Vaccines Revenue by Application (2025-2030)
5.2.3 Global Influenza Drugs and Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Influenza Drugs and Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 CSL
6.1.1 CSL Corporation Information
6.1.2 CSL Description and Business Overview
6.1.3 CSL Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 CSL Influenza Drugs and Vaccines Product Portfolio
6.1.5 CSL Recent Developments/Updates
6.2 Bristol Myers Squibb
6.2.1 Bristol Myers Squibb Corporation Information
6.2.2 Bristol Myers Squibb Description and Business Overview
6.2.3 Bristol Myers Squibb Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bristol Myers Squibb Influenza Drugs and Vaccines Product Portfolio
6.2.5 Bristol Myers Squibb Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Corporation Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AstraZeneca Influenza Drugs and Vaccines Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Eli Lilly
6.4.1 Eli Lilly Corporation Information
6.4.2 Eli Lilly Description and Business Overview
6.4.3 Eli Lilly Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Eli Lilly Influenza Drugs and Vaccines Product Portfolio
6.4.5 Eli Lilly Recent Developments/Updates
6.5 Roche
6.5.1 Roche Corporation Information
6.5.2 Roche Description and Business Overview
6.5.3 Roche Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Roche Influenza Drugs and Vaccines Product Portfolio
6.5.5 Roche Recent Developments/Updates
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 GlaxoSmithKline Influenza Drugs and Vaccines Product Portfolio
6.6.5 GlaxoSmithKline Recent Developments/Updates
6.7 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Influenza Drugs and Vaccines Product Portfolio
6.7.5 Novartis Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Pfizer Influenza Drugs and Vaccines Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Corporation Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Sanofi Influenza Drugs and Vaccines Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
6.10 Bayer
6.10.1 Bayer Corporation Information
6.10.2 Bayer Description and Business Overview
6.10.3 Bayer Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bayer Influenza Drugs and Vaccines Product Portfolio
6.10.5 Bayer Recent Developments/Updates
6.11 Celgene
6.11.1 Celgene Corporation Information
6.11.2 Celgene Influenza Drugs and Vaccines Description and Business Overview
6.11.3 Celgene Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Celgene Influenza Drugs and Vaccines Product Portfolio
6.11.5 Celgene Recent Developments/Updates
6.12 Seqirus
6.12.1 Seqirus Corporation Information
6.12.2 Seqirus Influenza Drugs and Vaccines Description and Business Overview
6.12.3 Seqirus Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Seqirus Influenza Drugs and Vaccines Product Portfolio
6.12.5 Seqirus Recent Developments/Updates
6.13 Protein Sciences Corporation
6.13.1 Protein Sciences Corporation Corporation Information
6.13.2 Protein Sciences Corporation Influenza Drugs and Vaccines Description and Business Overview
6.13.3 Protein Sciences Corporation Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Protein Sciences Corporation Influenza Drugs and Vaccines Product Portfolio
6.13.5 Protein Sciences Corporation Recent Developments/Updates
6.14 Serum Institute of India
6.14.1 Serum Institute of India Corporation Information
6.14.2 Serum Institute of India Influenza Drugs and Vaccines Description and Business Overview
6.14.3 Serum Institute of India Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Serum Institute of India Influenza Drugs and Vaccines Product Portfolio
6.14.5 Serum Institute of India Recent Developments/Updates
6.15 Emergent Biosolutions
6.15.1 Emergent Biosolutions Corporation Information
6.15.2 Emergent Biosolutions Influenza Drugs and Vaccines Description and Business Overview
6.15.3 Emergent Biosolutions Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Emergent Biosolutions Influenza Drugs and Vaccines Product Portfolio
6.15.5 Emergent Biosolutions Recent Developments/Updates
6.16 BioCryst Pharmaceuticals
6.16.1 BioCryst Pharmaceuticals Corporation Information
6.16.2 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Description and Business Overview
6.16.3 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.16.4 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product Portfolio
6.16.5 BioCryst Pharmaceuticals Recent Developments/Updates
6.17 Alvogen
6.17.1 Alvogen Corporation Information
6.17.2 Alvogen Influenza Drugs and Vaccines Description and Business Overview
6.17.3 Alvogen Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Alvogen Influenza Drugs and Vaccines Product Portfolio
6.17.5 Alvogen Recent Developments/Updates
6.18 Viatris
6.18.1 Viatris Corporation Information
6.18.2 Viatris Influenza Drugs and Vaccines Description and Business Overview
6.18.3 Viatris Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Viatris Influenza Drugs and Vaccines Product Portfolio
6.18.5 Viatris Recent Developments/Updates
6.19 Hulan Bio
6.19.1 Hulan Bio Corporation Information
6.19.2 Hulan Bio Influenza Drugs and Vaccines Description and Business Overview
6.19.3 Hulan Bio Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Hulan Bio Influenza Drugs and Vaccines Product Portfolio
6.19.5 Hulan Bio Recent Developments/Updates
6.20 Changchun Institute of Biological
6.20.1 Changchun Institute of Biological Corporation Information
6.20.2 Changchun Institute of Biological Influenza Drugs and Vaccines Description and Business Overview
6.20.3 Changchun Institute of Biological Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Changchun Institute of Biological Influenza Drugs and Vaccines Product Portfolio
6.20.5 Changchun Institute of Biological Recent Developments/Updates
6.21 Jiangsu GDK
6.21.1 Jiangsu GDK Corporation Information
6.21.2 Jiangsu GDK Influenza Drugs and Vaccines Description and Business Overview
6.21.3 Jiangsu GDK Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Jiangsu GDK Influenza Drugs and Vaccines Product Portfolio
6.21.5 Jiangsu GDK Recent Developments/Updates
6.22 Sinovac
6.22.1 Sinovac Corporation Information
6.22.2 Sinovac Influenza Drugs and Vaccines Description and Business Overview
6.22.3 Sinovac Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Sinovac Influenza Drugs and Vaccines Product Portfolio
6.22.5 Sinovac Recent Developments/Updates
6.23 Beike Bio
6.23.1 Beike Bio Corporation Information
6.23.2 Beike Bio Influenza Drugs and Vaccines Description and Business Overview
6.23.3 Beike Bio Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Beike Bio Influenza Drugs and Vaccines Product Portfolio
6.23.5 Beike Bio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Influenza Drugs and Vaccines Industry Chain Analysis
7.2 Influenza Drugs and Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Influenza Drugs and Vaccines Production Mode & Process
7.4 Influenza Drugs and Vaccines Sales and Marketing
7.4.1 Influenza Drugs and Vaccines Sales Channels
7.4.2 Influenza Drugs and Vaccines Distributors
7.5 Influenza Drugs and Vaccines Customers
8 Influenza Drugs and Vaccines Market Dynamics
8.1 Influenza Drugs and Vaccines Industry Trends
8.2 Influenza Drugs and Vaccines Market Drivers
8.3 Influenza Drugs and Vaccines Market Challenges
8.4 Influenza Drugs and Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
